HypoglycemiaHyperglycemiaInsulin ComaBlood GlucoseHypoglycemic AgentsDiabetes Mellitus, Type 1InsulinBlood Glucose Self-MonitoringHemoglobin A, GlycosylatedInsulin, Long-ActingInsulin AspartInsulin Infusion SystemsInsulin, IsophaneNesidioblastosisDiabetes Mellitus, Type 2Insulin LisproBiphasic InsulinsDiabetes MellitusMetforminEpisode of CareGlucagonGlucoseDrug Administration ScheduleTreatment OutcomeHyperinsulinismDiabetes Mellitus, ExperimentalRisk FactorsGlucose Clamp TechniqueEpinephrinePancreatic PolypeptideC-PeptideGlucose Tolerance TestTime FactorsStreptozocinClinical AlarmsIslets of LangerhansGluconeogenesisFastingVentromedial Hypothalamic NucleusSulfonylurea CompoundsHydrocortisonePostprandial PeriodRecurrenceInsulinomaCongenital HyperinsulinismRetrospective StudiesPancreas, ArtificialInsulin-Secreting CellsDiabetic KetoacidosisGlipizideDiabetes ComplicationsGlucokinaseAcute DiseaseInsulin ResistanceInfant, NewbornNorepinephrineRats, Sprague-DawleyProspective StudiesPregnancy in DiabeticsHomeostasisCritical IllnessFatty Acids, NonesterifiedInfusions, IntravenousDiabetic AngiopathiesDiazoxideLiver3-Hydroxybutyric AcidMonitoring, AmbulatoryGlucagon-Like Peptide 1